A Challenging Case of Scleritis with Refractory Pressure Control
DOI:
https://doi.org/10.48560/rspo.33266Keywords:
Antibodies, Antineutrophil Cytoplasmic, Granulomatosis with PolyangiitisAbstract
Systemic pathologies frequently show detectable signs during ophthalmologic assessments, and early identification of these manifestations can profoundly influence the disease’s subsequent course. A 62-year-old man presented to the emergency department of the Ophthalmology Department of Centro Hospitalar e Universitário de São João with bilateral painful red eye spanning the previous three months without concurrent ophthalmologic or systemic symptoms. Anterior segment examination assessment revealed bilateral diffuse, non-necrotizing, scleritis. Ocular hypertension (35 mmHg in the right eye and 40 mmHg in the left eye) was present. Past medical history included bilateral juvenile open-angle glaucoma. Systemic work-up results later disclosed anti-neutrophil cytoplasmatic auto-antibodies – proteinase 3 (ANCA-PR3) levels exceeding 200 U/mL. Granulomatosis with polyangiitis is known to elicit a range of ophthalmologic manifestations, affecting nearly 50% of the patients. This case underscores the importance of pursuing comprehensive systemic evaluations in patients with scleritis, even in the absence of overt systemic symptoms.Downloads
References
Dutta Majumder P, Agrawal R, McCluskey P, Biswas J. Current approach for the diagnosis and management of noninfective scleritis. Asia Pac J Ophthalmol. 2020;10:212-23. doi: 10.1097/APO.0000000000000341.
Arruza C, Requejo Figueroa GA, Colón J, Ramirez Marquez E, Puebla G, Ortega D, et al. Systemic disease associations in a cohort of Hispanic patients with scleritis. J Clin Med. 2023;12:1969. doi: 10.3390/jcm12051969.
Kharel Sitaula R, Maskey HMS, Chaudhary S, Jha S. Scleritis as the harbinger of Granulomatosis with polyangiitis. Ann Med Surg. 2022;84:104908. doi: 10.1016/j.amsu.2022.104908.
Spalton DJ, Graham EM, Page NG, Sanders MD. Ocular changes in limited forms of Wegener’s granulomatosis. Br J Ophthalmol. 1981;65:553-63. doi: 10.1136/bjo.65.8.553.
Abdou NI, Kullman GJ, Hoffman GS, Sharp GC, Specks U, McDonald T, et al. Wegener’s granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s. J Rheumatol. 2002;29:309-16.
Cogan DG. Corneoscleral lesions in periarteritis nodosa and Wegener’s granulomatosis. Trans Am Ophthalmol Soc. 1955;53:321-42; 42-4.
Sfiniadaki E, Tsiara I, Theodossiadis P, Chatziralli I. Ocular manifestations of granulomatosis with polyangiitis: a review of the literature. Ophthalmol Ther. 2019;8:227-34. doi: 10.1007/s40123-019-0176-8.
Haynes BF, Fishman ML, Fauci AS, Wolff SM. The ocular manifestations of Wegener’s granulomatosis. Fifteen years experience and review of the literature. Am J Med. 1977;63:131-41.
Rodriguez RR, Mena-Vázquez N, Cabezas-Lucena AM, Godoy-Navarrete F, Morales-Águila M, Arija SM. POS0246 The worldwide incidence and prevalence of anca vasculitis: a systematic review and meta-analysis of epidemiological studies. Ann Rheum Dis. 2021;80:344-5.
Cocho L, Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Sainz-de-la-Maza M, Foster CS. Scleritis in patients with granulomatosis with polyangiitis (Wegener). Br J Ophthalmol. 2016;100:1062-5. doi: 10.1136/bjophthalmol-2015-307460.
Yan Y, Zhang Q. Bilateral posterior scleritis presenting as the first manifestation of immunoglobulin a nephropathy: case report and review of the literature. Ocul Immunol Inflamm. 2016;24:43-8. doi: 10.3109/09273948.2014.964420.
Gedde SJ, Feuer WJ, Lim KS, Barton K, Goyal S, Ahmed IIK, et al. Treatment outcomes in the primary tube versus trabeculectomy study after 3 years of follow-up. Ophthalmology. 2020;127:333-45. doi: 10.1016/j.ophtha.2019.10.002.
European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition. Br J Ophthalmol. 2021;105:1-169. doi: 10.1136/bjophthalmol-2021-egsguidelines.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista Sociedade Portuguesa de Oftalmologia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Do not forget to download the Authorship responsibility statement/Authorization for Publication and Conflict of Interest.
The article can only be submitted with these two documents.
To obtain the Authorship responsibility statement/Authorization for Publication file, click here.
To obtain the Conflict of Interest file (ICMJE template), click here